227 related articles for article (PubMed ID: 28210256)
21. Genomic Characterization of
Kanmani P; Albarracin L; Kobayashi H; Hebert EM; Saavedra L; Komatsu R; Gatica B; Miyazaki A; Ikeda-Ohtsubo W; Suda Y; Aso H; Egusa S; Mishima T; Salas-Burgos A; Takahashi H; Villena J; Kitazawa H
Front Immunol; 2018; 9():2178. PubMed ID: 30319634
[TBL] [Abstract][Full Text] [Related]
22. Modulation of Respiratory TLR3-Anti-Viral Response by Probiotic Microorganisms: Lessons Learned from Lactobacillus rhamnosus CRL1505.
Kitazawa H; Villena J
Front Immunol; 2014; 5():201. PubMed ID: 24860569
[TBL] [Abstract][Full Text] [Related]
23.
Indo Y; Kitahara S; Tomokiyo M; Araki S; Islam MA; Zhou B; Albarracin L; Miyazaki A; Ikeda-Ohtsubo W; Nochi T; Takenouchi T; Uenishi H; Aso H; Takahashi H; Kurata S; Villena J; Kitazawa H
Front Immunol; 2021; 12():652923. PubMed ID: 34163470
[TBL] [Abstract][Full Text] [Related]
24. Immunobiotic Bifidobacteria Strains Modulate Rotavirus Immune Response in Porcine Intestinal Epitheliocytes via Pattern Recognition Receptor Signaling.
Ishizuka T; Kanmani P; Kobayashi H; Miyazaki A; Soma J; Suda Y; Aso H; Nochi T; Iwabuchi N; Xiao JZ; Saito T; Villena J; Kitazawa H
PLoS One; 2016; 11(3):e0152416. PubMed ID: 27023883
[TBL] [Abstract][Full Text] [Related]
25. Improvement of Myelopoiesis in Cyclophosphamide-Immunosuppressed Mice by Oral Administration of Viable or Non-Viable
Gramajo Lopez A; Gutiérrez F; Saavedra L; Hebert EM; Alvarez S; Salva S
Front Immunol; 2021; 12():647049. PubMed ID: 33912172
[TBL] [Abstract][Full Text] [Related]
26. Immunobiotic Strains Modulate Toll-Like Receptor 3 Agonist Induced Innate Antiviral Immune Response in Human Intestinal Epithelial Cells by Modulating IFN Regulatory Factor 3 and NF-κB Signaling.
Kanmani P; Kim H
Front Immunol; 2019; 10():1536. PubMed ID: 31333667
[TBL] [Abstract][Full Text] [Related]
27. The Ability of Postimmunobiotics from
Raya Tonetti F; Clua P; Fukuyama K; Marcial G; Sacur J; Marranzino G; Tomokiyo M; Vizoso-Pinto G; Garcia-Cancino A; Kurata S; Kitazawa H; Villena J
Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36363777
[TBL] [Abstract][Full Text] [Related]
28. Exopolysaccharides From
Mizuno H; Tomotsune K; Islam MA; Funabashi R; Albarracin L; Ikeda-Ohtsubo W; Aso H; Takahashi H; Kimura K; Villena J; Sasaki Y; Kitazawa H
Front Microbiol; 2020; 11():894. PubMed ID: 32508770
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulatory Properties of Bacterium-Like Particles Obtained From Immunobiotic Lactobacilli: Prospects for Their Use as Mucosal Adjuvants.
Raya Tonetti F; Arce L; Salva S; Alvarez S; Takahashi H; Kitazawa H; Vizoso-Pinto MG; Villena J
Front Immunol; 2020; 11():15. PubMed ID: 32038659
[TBL] [Abstract][Full Text] [Related]
30. New immunobiotics from highly proteolytic
Elean M; Albarracín L; Cataldo PG; Londero A; Kitazawa H; Saavedra L; Villena J; Hebert EM
Benef Microbes; 2020 Aug; 11(4):375-390. PubMed ID: 32755264
[
